Drug for treating depression

Abstract

The invention discloses a drug for treating depression. The drug contains an effective amount of 4-{4-(4-fluorophenyl)-1-[1-(isoxazole-3-ylmethyl)piperidine-4-yl]-1H-imidazole-5-yl}pyrimidine-2-amine and an effective amount of fluoxetine, and the mass ratio of 4-{4-(4-fluorophenyl)-1-[1-(isoxazole-3-ylmethyl)piperidine-4-yl]-1H-imidazole-5-yl}pyrimidine-2-amine to fluoxetine is 3:1 to 6:1. Through combined use of specific drugs, side effects during treatment of depression are greatly reduced, pain of patients is reduced, and recovery of the patients is availed.

Description

technical field [0001] The invention relates to a medicine, in particular to a medicine for treating depression. Background technique [0002] Depression is a common mood disorder, which can be caused by various reasons. The main clinical feature is marked and persistent low mood, and the low mood is not commensurate with the situation. In severe cases, suicidal thoughts and behaviors may appear. Most cases have a tendency to relapse, and most of each attack can be relieved, and some may have residual symptoms or become chronic. [0003] Manic episodes can occur in at least 10% of patients with depression, at which point a diagnosis of bipolar disorder should be made. In addition, the depression we often talk about actually refers to the clinical major depression, and 16% of the population will be affected by it at some point in their lives. In addition to the severe emotional and social costs of suffering from depression, the economic costs are also enormous. According t...

AI Technical Summary

Problems solved by technology

[0013] However, most of the existing drugs are expensive and accompanied by relatively large side effects